Regarding safety, the most common grade 3 or 4 AEs reported in the CARES-310 trial included hypertension, palmar-plantar erythrodysesthesia syndrome, elevated aspartate aminotransferase (AST), and elevated alanine aminotransferase (ALT) (11). The gene discussed is GPT; the disease is Hypertension.